VOR Financial Statements

Balance sheet, income statement, cash flow, and dividends for Vor Biopharma Inc (VOR).


$76.23M Market Cap.

As of 03/20/2025 5:00 PM ET (MRY) • Disclaimer

VOR Market Cap. (MRY)


VOR Shares Outstanding (MRY)


VOR Assets (MRY)


Total Assets

$142.89M

Total Liabilities

$46.23M

Total Investments

$9.98M

VOR Income (MRY)


Revenue

$0

Net Income

-$116.91M

Operating Expense

$121.19M

VOR Cash Flow (MRY)


CF Operations

-$99.66M

CF Investing

$96.86M

CF Financing

$53.39M

VOR Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

VOR Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$142,891,000 (-27.88%)

$198,126,000 (-33.82%)

$299,366,000 (23.40%)

$242,590,000 (219.58%)

Assets Current

$96,507,000 (-31.46%)

$140,803,000 (-40.58%)

$236,950,000 (10.52%)

$214,399,000 (336.60%)

Assets Non-Current

$46,384,000 (-19.08%)

$57,323,000 (-8.16%)

$62,416,000 (121.40%)

$28,191,000 (5.18%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$96,664,000 (-35.87%)

$150,724,000 (-39.86%)

$250,607,000 (15.88%)

$216,263,000 (466.14%)

Property Plant & Equipment Net

$41,588,000 (-16.99%)

$50,098,000 (-12.23%)

$57,078,000 (153.42%)

$22,523,000 (3.10%)

Cash & Equivalents

$84,362,000 (149.79%)

$33,773,000 (-43.82%)

$60,119,000 (-50.81%)

$122,214,000 (143.95%)

Accumulated Other Comprehensive Income

$22,000 (128.57%)

-$77,000 (90.00%)

-$770,000 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$9,977,000 (-90.57%)

$105,815,000 (-38.67%)

$172,539,000 (96.81%)

$87,668,000 (0%)

Investments Current

$9,977,000 (-90.57%)

$105,815,000 (-38.67%)

$172,539,000 (96.81%)

$87,668,000 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$1,505,000 (84.66%)

$815,000 (-54.01%)

$1,772,000 (14.69%)

$1,545,000 (-34.56%)

Accumulated Retained Earnings (Deficit)

-$456,994,000 (-34.38%)

-$340,080,000 (-53.04%)

-$222,217,000 (-70.77%)

-$130,123,000 (-112.54%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$31,830,000 (-10.74%)

$35,660,000 (-8.36%)

$38,912,000 (116.02%)

$18,013,000 (-1.53%)

Debt Current

$4,215,000 (10.05%)

$3,830,000 (17.05%)

$3,272,000 (77.92%)

$1,839,000 (113.09%)

Debt Non-Current

$27,615,000 (-13.24%)

$31,830,000 (-10.69%)

$35,640,000 (120.35%)

$16,174,000 (-7.21%)

Total Liabilities

$46,227,000 (-2.48%)

$47,402,000 (-2.78%)

$48,759,000 (85.21%)

$26,327,000 (-4.74%)

Liabilities Current

$18,612,000 (19.52%)

$15,572,000 (18.70%)

$13,119,000 (29.21%)

$10,153,000 (-0.53%)

Liabilities Non-Current

$27,615,000 (-13.24%)

$31,830,000 (-10.69%)

$35,640,000 (120.35%)

$16,174,000 (-7.21%)

VOR Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$27,875,000 (-12.12%)

$31,721,000 (9.88%)

$28,868,000 (34.34%)

$21,489,000 (82.92%)

Research & Development Expense

$93,310,000 (-1.07%)

$94,315,000 (46.11%)

$64,550,000 (35.81%)

$47,529,000 (50.32%)

Operating Expenses

$121,185,000 (-3.85%)

$126,036,000 (34.92%)

$93,418,000 (35.35%)

$69,018,000 (59.15%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$116,914,000 (0.81%)

-$117,863,000 (-27.98%)

-$92,094,000 (-33.67%)

-$68,899,000 (-58.98%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$116,914,000 (0.81%)

-$117,863,000 (-27.98%)

-$92,094,000 (-33.67%)

-$68,899,000 (-58.98%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$1,228,000 (-79.27%)

Net Income Common Stock

-$116,914,000 (0.81%)

-$117,863,000 (-27.98%)

-$92,094,000 (-31.32%)

-$70,127,000 (-42.36%)

Weighted Average Shares

$68,705,639 (2.25%)

$67,191,973 (69.89%)

$39,551,420 (18.30%)

$33,433,214 (15548.00%)

Weighted Average Shares Diluted

$68,705,639 (2.25%)

$67,191,973 (69.89%)

$39,551,420 (18.30%)

$33,433,214 (15548.00%)

Earning Before Interest & Taxes (EBIT)

-$116,914,000 (0.81%)

-$117,863,000 (-27.98%)

-$92,094,000 (-33.67%)

-$68,899,000 (-58.98%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$121,185,000 (3.85%)

-$126,036,000 (-34.92%)

-$93,418,000 (-35.35%)

-$69,018,000 (-59.15%)

VOR Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$96,857,000 (36.40%)

$71,008,000 (175.47%)

-$94,091,000 (-2.66%)

-$91,651,000 (-2102.62%)

Net Cash Flow from Financing

$53,392,000 (1717.29%)

$2,938,000 (-97.49%)

$117,140,000 (-49.71%)

$232,911,000 (182.23%)

Net Cash Flow from Operations

-$99,660,000 (0.63%)

-$100,292,000 (-17.79%)

-$85,144,000 (-23.14%)

-$69,144,000 (-90.52%)

Net Cash Flow / Change in Cash & Cash Equivalents

$50,589,000 (292.02%)

-$26,346,000 (57.57%)

-$62,095,000 (-186.10%)

$72,116,000 (71.41%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$97,086,000 (34.70%)

$72,077,000 (184.17%)

-$85,629,000 (2.42%)

-$87,757,000 (0%)

Capital Expenditure

-$229,000 (78.58%)

-$1,069,000 (87.37%)

-$8,462,000 (-117.31%)

-$3,894,000 (6.42%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$53,392,000 (1717.29%)

$2,938,000 (-97.49%)

$117,140,000 (-37.54%)

$187,536,000 (72307.72%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$9,847,000 (-26.31%)

$13,362,000 (24.94%)

$10,695,000 (147.86%)

$4,315,000 (221.54%)

Depreciation Amortization & Accretion

$8,569,000 (4.26%)

$8,219,000 (-8.27%)

$8,960,000 (101.30%)

$4,451,000 (220.91%)

VOR Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-119.70% (-93.06%)

-62.00% (-31.08%)

-47.30% (-63.10%)

-29.00% (-122.52%)

Return on Average Assets (ROAA)

-82.40% (-66.13%)

-49.60% (-29.84%)

-38.20% (-45.80%)

-26.20% (77.20%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-124.60% (-132.90%)

-53.50% (-13.11%)

-47.30% (31.05%)

-68.60% (73.47%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-0.65 (49.22%)

-1.29 (54.94%)

-2.85 (48.42%)

-5.53

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.79 (-22.04%)

1.01 (-1.36%)

1.03 (-48.80%)

2

Debt to Equity Ratio (D/E)

0.48 (52.23%)

0.31 (61.03%)

0.2 (59.84%)

0.12 (126.07%)

Earnings Per Share (EPS)

-1.7 (2.86%)

-1.75 (24.89%)

-2.33 (-10.95%)

-2.1 (99.09%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.45 (3.64%)

-1.51 (36.25%)

-2.37 (-8.33%)

-2.19 (98.85%)

Book Value Per Share (BVPS)

1.41 (-37.27%)

2.24 (-64.60%)

6.34 (-2.06%)

6.47 (102.34%)

Tangible Assets Book Value Per Share (TABVPS)

2.08 (-29.47%)

2.95 (-61.04%)

7.57 (4.31%)

7.26 (-97.96%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

-1 (66.67%)

-3 (25.00%)

-4

Enterprise Value Over EBITDA (EV/EBITDA)

-0.5 (61.56%)

-1.29 (54.10%)

-2.82 (40.57%)

-4.74

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

5.18 (-42.66%)

9.04 (-49.94%)

18.06 (-14.47%)

21.12 (338.93%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$99,889,000 (1.45%)

-$101,361,000 (-8.28%)

-$93,606,000 (-28.16%)

-$73,038,000 (-80.55%)

Enterprise Value (EV)

$53,870,709 (-61.99%)

$141,720,796 (-39.48%)

$234,183,951 (-23.34%)

$305,469,036

Earnings Before Tax (EBT)

-$116,914,000 (0.81%)

-$117,863,000 (-27.98%)

-$92,094,000 (-33.67%)

-$68,899,000 (-58.98%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$108,345,000 (1.18%)

-$109,644,000 (-31.89%)

-$83,134,000 (-28.99%)

-$64,448,000 (-53.63%)

Invested Capital

$71,747,000 (-61.10%)

$184,441,000 (-30.41%)

$265,040,000 (106.68%)

$128,236,000 (278.32%)

Working Capital

$77,895,000 (-37.80%)

$125,231,000 (-44.05%)

$223,831,000 (9.59%)

$204,246,000 (425.07%)

Tangible Asset Value

$142,891,000 (-27.88%)

$198,126,000 (-33.82%)

$299,366,000 (23.40%)

$242,590,000 (219.58%)

Market Capitalization

$76,227,709 (-50.04%)

$152,562,796 (-40.67%)

$257,129,951 (-40.66%)

$433,304,036

Average Equity

$97,683,500 (-48.60%)

$190,042,500 (-2.39%)

$194,690,500 (-19.43%)

$241,628,750 (731.76%)

Average Assets

$141,875,000 (-40.24%)

$237,417,000 (-1.55%)

$241,155,750 (-9.79%)

$267,326,000 (523.62%)

Invested Capital Average

$93,833,250 (-57.39%)

$220,231,500 (13.11%)

$194,697,000 (93.76%)

$100,485,000 (499.71%)

Shares

68,673,612 (1.28%)

67,805,687 (75.36%)

38,666,158 (3.69%)

37,289,504 (7.64%)